Catherine’s work focuses on the legal issues around migration, together with the legal and constitutional issues associated with Brexit, in particular examining the Withdrawal Agreement and the Trade ...

Healthcare is undergoing a quiet revolution. Paper trails are giving way to digital records, and AI scribes are becoming official note-takers of patient–clinician conversations. This shift from ...

Jamie works on the ethical, legal and societal challenges posed by scientific and technological innovation in the context of health as part of the Humanities team. Prior to joining the PHG Foundation, ...

Heather Kompart is a policy analyst in the biomedical science team at the PHG Foundation, where she focuses on integrating genomic technologies into healthcare to enhance diagnosis and treatment. Her ...

We are an exempt charity under the Charities Act 2011 and regulated by the Office for Students (OFS) as a connected institution of the University of Cambridge. We are also a registered company no.

Patricia is a Policy Analyst in the humanities team. She works on legal and ethical issues for data protection and data governance introduced by scientific health innovations. She is completing a PhD ...

Mike grew up in the Seattle area before beginning undergraduate study in 1999 at the University of Washington, where he graduated with BSc’s in biochemistry and economics. As a 19 year-old, Mike began ...

Effective data sharing underpins much of health care, and new ways of integrating and mining data support existing practice and inform novel approaches. The regulatory framework that governs the ...

The UK is a recognised powerhouse for genomic science and medicine. Genomics England’s 100,000 Genomes Project is the largest sequencing project of its kind in the world and, building on these ...

The Wellcome Trust recently announced that they are funding a research programme to investigate synthetic human genomes, and Laura Blackburn, PHG Foundation’s Head of Science, had the opportunity to ...

A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI). The MHRA proposed new five-year ...